Surgery for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) arises commonly on a background of chronic liver disease and more rarely in a normal liver. It can be solitary or multifocal and is best managed in liver transplant centres which offer the whole range of treatment modalities and specialists.
Management of these patients is complex and requires the input of liver physicians, as decompensation after surgery or even after less invasive treatments, such as transarterial embolisation techniques, may occur.
Liver transplantation and surgical resection are the only potentially curative options, but we also have considerable experience with transarterial embolisation (also used as a bridge to liver transplant), ethanol injection, radiofrequency ablation (RFA) and selective intrahepatic radiotherapy (SIRT) for cases with inoperable disease. All these procedures are carried out by our consultant radiologists.
Chemotherapy with Sorafenib is also available to private patients, as it has been shown to improve survival in the context of controlled randomised trials.